IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, A. J.
Right arrow Articles by Gardner, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barber, A. J.
Right arrow Articles by Gardner, T. W.
(Investigative Ophthalmology and Visual Science. 2000;41:3561-3568.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Altered Expression of Retinal Occludin and Glial Fibrillary Acidic Protein in Experimental Diabetes

Alistair J. Barber1, David A. Antonetti1,2, Thomas W. Gardner1,2 and The Penn State Retina Research Group

From the The Ulerich Ophthalmology Research Laboratory 1 Departments of Ophthalmology and 2 Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, Pennsylvania.

PURPOSE. To investigate how diabetes alters vascular endothelial cell tight junction protein and glial cell morphology at the blood–retinal barrier (BRB).

METHODS. The distribution of the glial marker, glial fibrillary acidic protein (GFAP), and the endothelial cell tight junction protein occludin were explored by immunofluorescence histochemistry in flatmounted retinas of streptozotocin (STZ)-diabetic and age-matched control rats, and in BB/Wor diabetes-prone and age-matched diabetes-resistant rats.

RESULTS. GFAP immunoreactivity was limited to astrocytes in control retinas. Two months of STZ-diabetes reduced GFAP immunoreactivity in astrocytes and increased GFAP immunoreactivity in small groups of Müller cells. After 4 months of STZ-induced diabetes, all Müller cells had intense GFAP immunoreactivity, whereas there was virtually none in the astrocytes. BB/Wor diabetic rats had similar changes in GFAP immunoreactivity. Occludin immunoreactivity in normal rats was greatest in the capillary bed of the outer plexiform layer and arterioles of the inner retina but much less intense in the postcapillary venules. Diabetes reduced occludin immunoreactivity in the capillaries and induced redistribution from continuous cell border to interrupted, punctate immunoreactivity in the arterioles. Forty-eight hours of insulin treatment reversed the pattern of GFAP and occludin immunoreactivity in the STZ-diabetic rats.

CONCLUSIONS. Diabetes alters GFAP expression in retinal glial cells, accompanied by reduction and redistribution of occludin in endothelial cells. These changes are consistent with the concept that altered glial–endothelial cell interactions at the BRB contribute to diabetic retinopathy.




This article has been cited by other articles:


Home page
FASEB J.Home page
D. Navaratna, G. Menicucci, J. Maestas, R. Srinivasan, P. McGuire, and A. Das
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes
FASEB J, September 1, 2008; 22(9): 3310 - 3317.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Kohzaki, A. J. Vingrys, and B. V. Bui
Early Inner Retinal Dysfunction in Streptozotocin-Induced Diabetic Rats
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3595 - 3604.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. W. Bronson-Castain, M. A. Bearse Jr, Y. Han, M. E. Schneck, S. Barez, and A. J. Adams
Association between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5250 - 5256.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. C. Leal, A. Manivannan, K.-I. Hosoya, T. Terasaki, J. Cunha-Vaz, A. F. Ambrosio, and J. V. Forrester
Inducible Nitric Oxide Synthase Isoform Is a Key Mediator of Leukostasis and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5257 - 5265.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Vincent and S. Mohr
Inhibition of Caspase-1/Interleukin-1{beta} Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia
Diabetes, January 1, 2007; 56(1): 224 - 230.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Zheng, R. E. Anderson, M.-P. Agbaga, E. B. Rucker III, and Y.-Z. Le
Loss of BCL-XL in Rod Photoreceptors: Increased Susceptibility to Bright Light Stress
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5583 - 5589.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. E. Fox, X. Han, S. Kelly, A. H. Merrill Jr., R. E. Martin, R. E. Anderson, T. W. Gardner, and M. Kester
Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy
Diabetes, December 1, 2006; 55(12): 3573 - 3580.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. S. Harhaj, E. A. Felinski, E. B. Wolpert, J. M. Sundstrom, T. W. Gardner, and D. A. Antonetti
VEGF Activation of Protein Kinase C Stimulates Occludin Phosphorylation and Contributes to Endothelial Permeability
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5106 - 5115.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al.
Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Diabetes, September 1, 2006; 55(9): 2401 - 2411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. A. Kramerov, M. Saghizadeh, H. Pan, A. Kabosova, M. Montenarh, K. Ahmed, J. S. Penn, C. K. Chan, D. R. Hinton, M. B. Grant, et al.
Expression of Protein Kinase CK2 in Astroglial Cells of Normal and Neovascularized Retina
Am. J. Pathol., May 1, 2006; 168(5): 1722 - 1736.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. E.N. Reiter, X. Wu, L. Sandirasegarane, M. Nakamura, K. A. Gilbert, R. S.J. Singh, P. E. Fort, D. A. Antonetti, and T. W. Gardner
Diabetes reduces Basal retinal insulin receptor signaling: reversal with systemic and local insulin.
Diabetes, April 1, 2006; 55(4): 1148 - 1156.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T. S. Kern, and D. F. Chen
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4281 - 4287.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. K.H. Cheung, M. K.L. Fung, A. C.Y. Lo, T. T.L. Lam, K. F. So, S. S.M. Chung, and S. K. Chung
Aldose Reductase Deficiency Prevents Diabetes-Induced Blood-Retinal Barrier Breakdown, Apoptosis, and Glial Reactivation in the Retina of db/db Mice
Diabetes, November 1, 2005; 54(11): 3119 - 3125.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. J. Layton, G. Chidlow, R. J. Casson, J. P. M. Wood, M. Graham, and N. N. Osborne
Monocarboxylate Transporter Expression Remains Unchanged during the Development of Diabetic Retinal Neuropathy in the Rat
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2878 - 2885.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Xu, R. Dawson, I. J. Crane, and J. Liversidge
Leukocyte Diapedesis In Vivo Induces Transient Loss of Tight Junction Protein at the Blood-Retina Barrier
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2487 - 2494.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Klemp, B. Sander, P. B. Brockhoff, A. Vaag, H. Lund-Andersen, and M. Larsen
The Multifocal ERG in Diabetic Patients without Retinopathy during Euglycemic Clamping
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2620 - 2626.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson
The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Barber and D. A. Antonetti
Mapping the Blood Vessels with Paracellular Permeability in the Retinas of Diabetic Rats
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5410 - 5416.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje, and M. Lorenzi
A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat
Diabetes, February 1, 2003; 52(2): 506 - 511.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Q. Li and D. G. Puro
Diabetes-Induced Dysfunction of the Glutamate Transporter in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3109 - 3116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakamura, A. J. Barber, D. A. Antonetti, K. F. LaNoue, K. A. Robinson, M. G. Buse, and T. W. Gardner
Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons
J. Biol. Chem., November 16, 2001; 276(47): 43748 - 43755.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. J. Gastinger, A. J. Barber, S. A. Khin, C. S. McRill, T. W. Gardner, and D. W. Marshak
Abnormal Centrifugal Axons in Streptozotocin- Diabetic Rat Retinas
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2679 - 2685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Barber, M. Nakamura, E. B. Wolpert, C. E. N. Reiter, G. M. Seigel, D. A. Antonetti, and T. W. Gardner
Insulin Rescues Retinal Neurons from Apoptosis by a Phosphatidylinositol 3-Kinase/Akt-mediated Mechanism That Reduces the Activation of Caspase-3
J. Biol. Chem., August 24, 2001; 276(35): 32814 - 32821.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology